MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/asj/sjaf031

Медицинская библиотека · Aesthetic surgery journal · 2025

A Randomized, Double-Blind, Placebo-Controlled, Multicentered Study to Evaluate the Efficacy and Safety of MEI005 in Reducing Submental Fat in Chinese Adults.

Ting Wenyun, Wen Junxian, Li Zhijin, Sun Jiaming, Zhang Jiaping, Shu Maoguo, Liu Hongwei, He Li, Yu Bo, Jiang Nan, Xue Chunyu, Tan Qian, Xu Xuewen, Wu Sufan, Jian Dan, Zhao Hongyi, Wang Lei, Yu Nanze, Wang Xiaojun

СтатьяМногоцентровое исследованиеРандомизированное исследованиеКлиническое исследование III фазыПеревод в очереди

Аннотация

BACKGROUND

Submental fat (SMF) is a common aesthetic concern traditionally treated with liposuction. Nonsurgical alternatives, like injectable deoxycholic acid, are gaining popularity. However, no related products have been clinically approved in China.

OBJECTIVES

This study evaluated the efficacy and safety of MEI005, a deoxycholic acid-based injectable formulation, in reducing SMF in Chinese adults.

METHODS

This multicenter, randomized, double-blind, placebo-controlled Phase III trial included 325 Chinese adults with moderate-to-severe SMF. Participants received MEI005 or a placebo injection every 28 days for up to 6 sessions. Primary endpoints were ≥2-grade improvements in Clinician and Patient-Reported Submental Fat Rating Scales (CR-SMFRS and PR-SMFRS). Secondary endpoints included SMF volume reductions measured by MRI; patient-reported outcomes on the Patient-Reported Submental Fat Impact Scale (PR-SMFIS) and Subject Self-Rating Scale (SSRS); and SMF thickness reductions measured by caliper. Adverse events (AEs), self-reports, clinical examinations, and checks for skin laxity were monitored.

RESULTS

At 12 weeks posttreatment, 18.9% of MEI005 recipients demonstrated simultaneously ≥2-grade CR-SMFRS and PR-SMFRS improvement vs 1.8% for placebo (P < .001). Additionally, 68.9% of MEI005 group participants achieved simultaneously ≥1-grade improvement in CR-SMFRS and PR-SMFRS, compared with 21.6% of placebo (P < .001). MRI revealed ≥10% SMF volume reduction in 50% of MEI005 patients vs 15.2% of placebo (P < .001). Scores on the PR-SMFIS and SSRSs showed greater psychological improvement and satisfaction among MEI005 recipients. Vernier caliper measurements showed a 21.42% thickness reduction vs 6.32% (P < .001). AEs were mostly mild to moderate.

CONCLUSIONS

MEI005 effectively reduces SMF, offering a safe, minimally invasive option for Chinese adults.

Для цитирования: Ting Wenyun, Wen Junxian, Li Zhijin, Sun Jiaming, Zhang Jiaping, Shu Maoguo, Liu Hongwei, He Li, Yu Bo, Jiang Nan, Xue Chunyu, Tan Qian, Xu Xuewen, Wu Sufan, Jian Dan, Zhao Hongyi, Wang Lei, Yu Nanze, Wang Xiaojun. A Randomized, Double-Blind, Placebo-Controlled, Multicentered Study to Evaluate the Efficacy and Safety of MEI005 in Reducing Submental Fat in Chinese Adults.. Aesthetic surgery journal. 2025. DOI: 10.1093/asj/sjaf031.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.